ITMI20031098A1 - Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono - Google Patents

Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono

Info

Publication number
ITMI20031098A1
ITMI20031098A1 IT001098A ITMI20031098A ITMI20031098A1 IT MI20031098 A1 ITMI20031098 A1 IT MI20031098A1 IT 001098 A IT001098 A IT 001098A IT MI20031098 A ITMI20031098 A IT MI20031098A IT MI20031098 A1 ITMI20031098 A1 IT MI20031098A1
Authority
IT
Italy
Prior art keywords
formulations containing
alzheimer disease
useful compounds
disease therapy
therapy
Prior art date
Application number
IT001098A
Other languages
English (en)
Inventor
Ezio Bombardelli
Gabriele Fontana
Luisella Verotta
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Priority to IT001098A priority Critical patent/ITMI20031098A1/it
Publication of ITMI20031098A0 publication Critical patent/ITMI20031098A0/it
Priority to KR1020057022409A priority patent/KR20060012316A/ko
Priority to AU2004242838A priority patent/AU2004242838A1/en
Priority to RU2005136984/04A priority patent/RU2005136984A/ru
Priority to PCT/EP2004/005644 priority patent/WO2004106275A2/en
Priority to CNA2004800146347A priority patent/CN1795158A/zh
Priority to JP2006529917A priority patent/JP2007505152A/ja
Priority to CA002527354A priority patent/CA2527354A1/en
Priority to BRPI0410703-9A priority patent/BRPI0410703A/pt
Priority to EP04739354A priority patent/EP1638914A2/en
Priority to MXPA05012826A priority patent/MXPA05012826A/es
Priority to DE602004010100T priority patent/DE602004010100T2/de
Publication of ITMI20031098A1 publication Critical patent/ITMI20031098A1/it
Priority to US10/558,403 priority patent/US20070010507A1/en
Priority to EC2005006190A priority patent/ECSP056190A/es
Priority to IL172213A priority patent/IL172213A0/en
Priority to NO20056042A priority patent/NO20056042L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT001098A 2003-05-30 2003-05-30 Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono ITMI20031098A1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT001098A ITMI20031098A1 (it) 2003-05-30 2003-05-30 Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono
MXPA05012826A MXPA05012826A (es) 2003-05-30 2004-05-26 Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen.
JP2006529917A JP2007505152A (ja) 2003-05-30 2004-05-26 アルツハイマー病の治療に有効な化合物およびそれら化合物を含む製剤
BRPI0410703-9A BRPI0410703A (pt) 2003-05-30 2004-05-26 compostos úteis na terapia da doença de alzheimer e formulações contendo os mesmos
RU2005136984/04A RU2005136984A (ru) 2003-05-30 2004-05-26 Соединения, эффективные при лечении болезни альцгеймера, и их содержащие композиции
PCT/EP2004/005644 WO2004106275A2 (en) 2003-05-30 2004-05-26 Compounds useful in the therapy of alzheimer’s disease and formulations containing them
CNA2004800146347A CN1795158A (zh) 2003-05-30 2004-05-26 可用于治疗阿尔茨海默病的化合物和含有它们的制剂
KR1020057022409A KR20060012316A (ko) 2003-05-30 2004-05-26 알츠하이머병의 치료에 유용한 화합물과 그것들을 함유한제형
CA002527354A CA2527354A1 (en) 2003-05-30 2004-05-26 Compounds useful in the therapy of alzheimer`s disease and formulations containing them
AU2004242838A AU2004242838A1 (en) 2003-05-30 2004-05-26 Compounds useful in the therapy of Alzheimer's disease and formulations containing them
EP04739354A EP1638914A2 (en) 2003-05-30 2004-05-26 Compounds useful in the therapy of alzheimer's disease and formulations containing them
DE602004010100T DE602004010100T2 (de) 2003-05-30 2004-05-28 Durch coazervation hergestellte mikrokapseln mit einem wirkstoff in ethylcellulose als hüllpolymer
US10/558,403 US20070010507A1 (en) 2003-05-30 2005-05-26 Compounds useful in the therapy of alzheimer's disease and formulations containing them
EC2005006190A ECSP056190A (es) 2003-05-30 2005-11-28 Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen
IL172213A IL172213A0 (en) 2003-05-30 2005-11-28 Compounds useful in the therapy of alzheimer's disease and formulations containing them
NO20056042A NO20056042L (no) 2003-05-30 2005-12-19 Forbindelser som er anvendelige til behandling av Alzheimers sykdom samt formuleringer inneholdende disse

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001098A ITMI20031098A1 (it) 2003-05-30 2003-05-30 Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono

Publications (2)

Publication Number Publication Date
ITMI20031098A0 ITMI20031098A0 (it) 2003-05-30
ITMI20031098A1 true ITMI20031098A1 (it) 2004-11-30

Family

ID=30131121

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001098A ITMI20031098A1 (it) 2003-05-30 2003-05-30 Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono

Country Status (16)

Country Link
US (1) US20070010507A1 (it)
EP (1) EP1638914A2 (it)
JP (1) JP2007505152A (it)
KR (1) KR20060012316A (it)
CN (1) CN1795158A (it)
AU (1) AU2004242838A1 (it)
BR (1) BRPI0410703A (it)
CA (1) CA2527354A1 (it)
DE (1) DE602004010100T2 (it)
EC (1) ECSP056190A (it)
IL (1) IL172213A0 (it)
IT (1) ITMI20031098A1 (it)
MX (1) MXPA05012826A (it)
NO (1) NO20056042L (it)
RU (1) RU2005136984A (it)
WO (1) WO2004106275A2 (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060287554A1 (en) * 2005-06-21 2006-12-21 Madsen Kevin K Process for producing inorganic salts of hop acids
EP1937226A2 (en) * 2005-09-23 2008-07-02 Alza Corporation Transdermal galantamine delivery system
EP2236160A3 (en) * 2009-03-31 2011-12-14 Sanovel Ilac Sanayi ve Ticaret A.S. Modified release dimebolin formulations
JP6013184B2 (ja) * 2009-10-02 2016-10-25 ブランシェット・ロックフェラー・ニューロサイエンスィズ・インスティテュート アルツハイマー病末梢細胞におけるｐｋｃアイソザイムプロセッシングの異常変化
DE102010024105A1 (de) 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
WO2017023791A1 (en) 2015-07-31 2017-02-09 The Johns Hopkins University Glutamine antagonists for the treatment of cognitive deficits

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE253033T1 (de) * 1998-02-13 2003-11-15 Schwabe Willmar Gmbh & Co Stabile hyperforin-salze, verfahren zu ihrer herstellung und verwendung zur therapie der alzheimerschen krankheit
AU3738700A (en) * 1999-03-15 2000-10-04 Shaman Pharmaceuticals, Inc. Stabilized bicyclo(3.3.1)nonenes and methods of use
MXPA04003734A (es) * 2001-10-26 2005-06-20 Metaproteomics Llc Composiciones de curcuminoide que presentan una inhibicion sinergica de la expresion y/o actividad de ciclooxigenasa-2.

Also Published As

Publication number Publication date
ITMI20031098A0 (it) 2003-05-30
ECSP056190A (es) 2006-08-30
DE602004010100T2 (de) 2008-09-18
MXPA05012826A (es) 2006-02-13
WO2004106275A2 (en) 2004-12-09
DE602004010100D1 (de) 2007-12-27
CN1795158A (zh) 2006-06-28
NO20056042L (no) 2005-12-19
BRPI0410703A (pt) 2006-06-13
JP2007505152A (ja) 2007-03-08
CA2527354A1 (en) 2004-12-09
WO2004106275A3 (en) 2005-03-17
RU2005136984A (ru) 2006-03-27
IL172213A0 (en) 2009-02-11
EP1638914A2 (en) 2006-03-29
US20070010507A1 (en) 2007-01-11
AU2004242838A1 (en) 2004-12-09
KR20060012316A (ko) 2006-02-07

Similar Documents

Publication Publication Date Title
ATE289514T1 (de) Vaginalpflegezusammensetzung
PT1501534E (pt) Formulacoes farmaceuticas
DK3494995T3 (da) Superfin formoterolformulering
IS8309A (is) Lyfjablöndur
DK1620118T3 (da) Reversible pegylerede lægemidler
PL380244A1 (pl) Nowe rozgałęzione siarczany do zastosowania w produktach do higieny osobistej
DE60304102D1 (de) Hautreinigungszusammensetzung
HK1095739A1 (en) Skin care composition
IS7715A (is) Nýjar lyfjasamsetningar úr módafíníl
DK1587478T3 (da) Farmaceutisk sammensætning
EP1670441A4 (en) FAST RESOLUTION FORMULATION
DK1596870T3 (da) Höjdosis-iblandronatformulering
ITMI20040198A1 (it) Dispositivo reattore-rigeneratore e suo impiego nella produzione di stirene
DE602004007464D1 (de) Haarkosmetik
ATE399523T1 (de) Haarbehandlungszusammensetzung
NO20054053D0 (no) Triazolforbindelser anvendbare i terapi.
DK1643976T3 (da) Farmaceutisk formulering omfattende levothyroxinnatrium
DK1597171T3 (da) Terapeutisk mikroskum
DE602004000627D1 (de) Hautreinigungsmittel
ITMI20031098A1 (it) Composti utili nella terapia del morbo di alzheimer e formulazioni che li contengono
ATE395899T1 (de) Haarbehandlungszusammensetzungen
ATE326208T1 (de) Haarbehandlungszusammensetzungen
IS7902A (is) Blettaeyðandi samsetning fyrir húðumhirðu
ATE515382T1 (de) Holzbehandlungsformulierung
ATE439120T1 (de) Haarpflegezusammensetzung